As activation of Hh and TGF‐β pathways in HSC plays an important role in liver fibrosis during NASH progression, we examined whether Oxy210 inhibits these pathways in primary human HSC. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.